Investing in Fuzhou 丨 Understand the development status and investment opportunities prospects of biomedicine in Fuzhou City (attached with analysis of the current status, spatial layout, major projects, investment opportunities, etc.)

1. Policy environment for biomedical industry in Fuzhou City

--Summarizing key policies for the biomedical industry in Fuzhou City

Since 2023, Fuzhou City has successively issued the "Notice on Issuing the 2025 Guidelines for the Application of Award Funds for the First Industrialization of Provincial Biomedical Innovation Products","Several Measures on Promoting the Deep Integration of Scientific and Technological Innovation and Industrial Innovation", and "Policies such as Fuzhou City's Support for Key Industries" clearly encourage the development of the biomedical industry, promote enterprise innovation, build industrial clusters, and cultivate key talents.

--Regional policies for the biomedical industry in Fuzhou City

In recent years, Fuzhou Gulou District, Fuzhou New District, Fuqing City, Minhou County and other jurisdictions have issued policies to encourage the development of the biomedical industry. The policies of the main jurisdictions are summarized as follows:

2. Map of the biomedical industry chain in Fuzhou City

--Map of the biomedical industry chain in Fuzhou City

The upstream of the biomedicine industry is mainly raw materials, including Chinese medicinal materials, pharmaceutical intermediates, raw materials, etc.; the middle reaches are the manufacturing of traditional Chinese medicines, chemical drugs, and biological drugs; and the downstream is the circulation link, including hospitals, pharmacies, and pharmaceutical e-commerce.

At present, Fuzhou has a large number of upstream and midstream enterprises in the biomedical industry chain such as Chinese herbal medicine planting, raw materials, medicinal excipients, traditional Chinese medicine pieces, and generic drugs. In terms of downstream channels, there are a large number of pharmacies.

Note: Data is as of March 16, 2026.

--Map of the biomedical industry chain in Fuzhou City (by regional dimension)

At present, Fuzhou biomedical upstream enterprises are mainly distributed in Fuqing City, Pingtan, Cangshan District, Gulou District and other jurisdictions; the middle reaches are mainly distributed in Gulou District, Cangshan District, Jin 'an District and other jurisdictions; the downstream are mainly distributed in Fuqing City, Cangshan District, Minhou County, Gulou District and other jurisdictions.

3. Development scale of biomedical industry in Fuzhou City

--Current situation of the scale of the biomedical industry in Fuzhou City

As of the end of 2024, the number of medical device registration and filing numbers in Fuzhou City has reached more than 1200. The cumulative number of patents in the field of biomedicine has reached 3546, and 28 generic drug varieties have passed consistency evaluation.

As of 2024, the scale of traditional Chinese medicine planting in Fuzhou City is relatively small, with the planting area of traditional Chinese medicines of about 10064 acres, accounting for about 1% of the planting area of Fujian Province; of which, the planting area of agricultural land is about 784 acres, and the planting area under forest is about 9280 acres. It mainly grows Chinese medicinal materials such as Dendrobium officinale and Polygonatum.

--Current situation of scale of each district in the biomedical industry in Fuzhou City

From the perspective of the development of major jurisdictions, as of 2025, there are 86 biopharmaceutical enterprises above the scale in Cangshan District, with an industrial scale exceeding 20 billion yuan; Minhou County broke through two medical gaps during the "14th Five-Year Plan" period; the biopharmaceutical industry in Fuqing City is based on API manufacturing and supplemented by medical devices and marine life.

4. Analysis of the layout of biomedical industry enterprises in Fuzhou City

--Total number of enterprises in the biomedical industry in Fuzhou City

Enterprise cat data shows that since 2020, the number of registered enterprises in the biopharmaceutical industry in Fuzhou City has shown a fluctuating and downward trend. In 2020, the number of registered enterprises exceeded 500. In 2025, the number of registered biopharmaceutical companies in Fuzhou City will be 126, a decrease of 19.2% from 2024.

Note: Data as of March 16, 2026, the same below

As of March 2026, there are 9 high-tech enterprises and 3 technology-based small and medium-sized enterprises in the biomedical industry in Fuzhou City. There are also three "little giants" that specialize in and develop new ones.

--Spatial layout of biomedical industry enterprises in Fuzhou City

Biomedical enterprises Fuzhou City are mainly distributed in Gulou District, Taijiang District, Changle District, Cangshan District, Minhou County, Fuqing City, Jin 'an District and other jurisdictions. Representative enterprises include Xilian Biotech, Haiwang Fuyao, Deji Pharmaceutical, Lizhu Group Fuxing Pharmaceutical, Yiheng Pharmaceutical, Meidelai, Haixi New Drug, etc.

--Spatial layout of biomedical industry carriers in Fuzhou City

Fuzhou City Biomedical Related Industrial Parks include Fuzhou High-tech Zone Biomedical and Electromechanical Industrial Park, New North Biotechnology Industrial Park, Fuzhou Jiangyin Port City Economic Zone, Fuzhou New Area Biomedical Industrial Park, etc. Among them, New North Biotechnology Industrial Park is still under construction and is expected to be put into operation by the end of 2026.

5. Combing major projects in the biomedical industry in Fuzhou City

At present, Fuzhou's biomedicine field mainly includes Fuzhou New Area Biomedicine Industrial Park (Phase I), Fuzhou Neurite Medical Isotope and Drug Industrialization Project (Phase I), Ruike Pharmaceutical Health Industrial Park (Phase II), Fuer Fluid Biomedicine Industrial Park, Fujian Xinbei Biotechnology Industrial Park, etc. The main project information is summarized as follows:

6. Analysis of investment opportunities in the biomedical industry in Fuzhou City

--Development prospects and plans of each city

According to the "Proposal of the Fuzhou Municipal Committee of the Communist Party of China on Formulating the 15th Five-Year Plan for National Economic and Social Development of Fuzhou City," during the "15th Five-Year Plan" period, Fuzhou will continue to expand the scale of the biomedical industry, build industrial clusters, strengthen industrial cooperation with Taiwan, and enhance the competitiveness of Fuzhou New Area in the field of biomedical science.

According to the industrial policies and government reports of the main jurisdictions, in the future, the main jurisdictions will focus on developing innovative drugs and high-end medical devices, accelerating the improvement of the industrial chain, and promoting the construction of industrial clusters.

--Summary of industrial advantages and investment opportunities

For more research and analysis in this industry, please refer to the "Development Prospects Prediction and Investment Strategic Planning Analysis Report of China Biomedical Industry" by the Institute of Prospective Industries.

At the same time, the Prospective Industry Research Institute also provides solutions such as industrial new track research, investment feasibility study, industrial planning, park planning, industrial investment, industrial map, industrial big data, smart investment promotion system, industry status certification, IPO consultation and fundraising feasibility study, Specialized and new little giant application, and the 15th Five-Year Plan. If you need to reproduce and quote the content of this article, please indicate the source of the data (Prospective Industry Research Institute).

For more in-depth industry analysis, you can also interact with 500+ economists and senior industry researchers. More enterprise data, enterprise information, and enterprise development are available in the [Enterprise Check Cat APP], the enterprise query platform with the highest cost performance and most complete functions.

Prospective Industry Research Institute-In-depth Report REPORTS

If you quote the data of this article in the prospectus or the company's annual report, please contact the Prospective Industry Research Institute at 400-068-7188.

Forward-looking Economist

This article explores Aromatherapy, fragrance, perfume, essential oil, non-fire aroma, aroma candle, rattan aroma, home aroma, natural aroma, diffuser, sharing the latest industry insights and offering practical references for enthusiasts.

Source: 前瞻产业研究院 (https://www.qianzhan.com/)

This article is reproduced from the original source for information sharing only. If it infringes any copyright, please contact us and we will remove it promptly.

© 2026 CeresMall | www.CeresMall.com